Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysis
Year: 2026
Type: article
Study design: Observational Study
DOI: 10.1093/jjco/hyag012
Authors: Shugo Yajima, Soichiro Yoshida, Wei Chen, Hiroyuki Sato, Akihiro Hirakawa, Hiroshi Fukushima, Yuki Nakamura, Hajime Tanaka, Masaharu Inoue, Noboru Numao, Atsushi Yoshinaga, Naoko Kawamura, Ichiro Yonese, Keita Izumi, Takanobu Yamamoto, Sho Uehara, Kotaro Suzuki, Masahiro Toide, Ryoji Takazawa, Saori Araki, Hitoshi Masuda, Yasuhisa Fujii
Institutions: National Cancer Center Hospital East, Institute of Science Tokyo, Saitama Cancer Center, The Cancer Institute Hospital, Soka Municipal Hospital, JA Toride Medical Center, Saitama Red Cross Hospital, Dokkyo Medical University Saitama Medical Center, Tokyo Metropolitan Tama-Nambu Chiiki Hospital, Tokyo Metropolitan Tama-Nambu Hospital, Showa General Hospital, Tsuchiura Kyodo General Hospital, Tokyo Metropolitan Ohtsuka Hospital, Kohnodai Hospital, National Center for Global Health and Medicine
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7125947673